About the Authors
- Ismail Mahat Bashir
-
Affiliations Walter Reed Project, Kenya Medical Research Institute, Kisumu, Kenya, Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
- Nekoye Otsyula
-
Affiliation Walter Reed Project, Kenya Medical Research Institute, Kisumu, Kenya
- George Awinda
-
Affiliation Walter Reed Project, Kenya Medical Research Institute, Kisumu, Kenya
- Michele Spring
-
Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
- Petra Schneider
-
¶Joint senior author.
Affiliation Institutes of Evolution, Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom
- John Njenga Waitumbi
-
* E-mail: john.waitumbi@usamru-k.org
¶Joint senior author.
Affiliation Walter Reed Project, Kenya Medical Research Institute, Kisumu, Kenya
Competing Interests
The authors wish to declare that GlaxoSmithKline Biologicals (GSK) provided their proprietary adjuvant “AS01B”. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Critical review and edits to the manuscript: PS. Conceived and designed the experiments: JNW NO MS. Performed the experiments: IMB GA. Analyzed the data: JNW IMB PS. Wrote the paper: JNW IMB PS NO MS.